Biblio Discovery — Demo Discovery Service

6 hasil untuk "Burak Okyar"

Menampilkan 1–6 · 0,32 detik · RSS

  1. Artikel Jurnal

    Combination csDMARD and Infliximab in Primary Hypertrophic Osteoarthropathy, a Case-Based Review

    Burak Okyar; İbrahim Halil Bilen; Fatih Yildiz

    Van Tıp Dergisi, Vol. 32 No. 2 · 2025 · Inggris · DOAJ Scopus

    An 18-year-old male patient presented with excessive sweating on the palms of the hands and soles of the feet. X-ray showed periostosis in the carpal and tarsal bones. Genetic analysis revealed c.1807C>T(p.Arg603Ter), a homozygous mutation, and PHO was diagnosed. The patient was treated with…

  2. Artikel Jurnal

    ADDING NINTEDANIB TO IMMUNOSUPPRESSIVE THERAPY IN CONNECTIVE TISSUE RELATED INTERSTITIAL LUNG DISEASES; CASE SERIES BASED ON REAL-LIFE DATA FROM A SINGLE CENTRE

    Burak Okyar; Nurhan Atilla; Gözde Yıldırım Çetin dkk.

    Rheumatology Quarterly, Vol. 3 No. 1 · 2025 · Inggris · DOAJ

    Connective tissue-related interstitial lung disease (CTD-ILD) is a severe process that progresses in approximately 30% of patients. These patients may need aggressive treatment. Therefore, new treatment strategies are being developed. Anti-fibrotic agents used in idiopathic pulmonary fibrosis are…

  3. Artikel Jurnal

    Evaluation of remission in patients with radiographic axial spondyloarthritis using an ultrasonography-based enthesitis score: a cross-sectional study

    Emrah Koç; Burak Okyar; Sibel Bakırcı dkk.

    Rheumatology, Vol. 63 No. 6 · 2025 · Inggris · DOAJ Scopus

    Introduction This study aimed to evaluate ultrasonographic entheseal abnormalities in patients with radiographic axial spondyloarthritis (r-axSpA) who were in clinical remission for at least 6 months and receiving either nonsteroidal anti-inflammatory drugs (NSAIDs) or biologic agents. Material and…

  4. Artikel Jurnal

    The correlation between serum YKL-40, proteinuria and inflammation in patients with systemic lupus erythematosus

    İlyas Öztürk; Fatma Betül Güzel; Serhat Kura dkk.

    Batı Karadeniz Tıp Dergisi, Vol. 10 No. 1 · 2026 · Turki · DOAJ

    Aim: YKL-40 is a protein associated with acute and chronic inflammation and cancer. Neutrophils, macrophages, and cancer cells normally produce it. It plays a role in cell proliferation, differentiation, angiogenesis, inflammation, and extracellular matrix remodeling. It is also a marker of…

  5. Artikel Jurnal

    COVID-19 vaccination in patients on biologic or targeted-synthetic disease modifying anti-rheumatic drug therapy: A multi center real-world data

    Tuba Demirci Yildirim; Cansu Akleylek; Derya Yıldırım dkk.

    Asian Pacific Journal of Tropical Medicine, Vol. 18 No. 2 · 2025 · Inggris · DOAJ Scopus

    Objective: To assess the effectiveness of COVID-19 vaccination in patients with rheumatic diseases undergoing biologic (bDMARDs) or targeted-synthetic disease-modifying anti-rheumatic drugs (tsDMARDs). Methods: This cross-sectional study was conducted at ten rheumatology clinics in Turkey between…

  6. Artikel Jurnal

    Clinical spectrum and outcomes of mononeuritis multiplex in rheumatic diseases: evidence from a nationwide multicenter study

    Firdevs Ulutaș; Meysere Nur Akuç; Burcu Yağız dkk.

    Therapeutic Advances in Musculoskeletal Disease, Vol. 18 · 2026 · Inggris · DOAJ Scopus

    Background: Mononeuritis multiplex (MM) is a severe and clinically heterogeneous form of peripheral neuropathy, most commonly arising in the context of systemic vasculitis in rheumatology practice. Despite its potential to cause substantial functional impairment, data on its clinical spectrum…